Pharma Veterans

Pharma Marketing by 2030 – Asrar Qureshi’s Blog Post #1148 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1148 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Timur Saglambilek Credit: Mikael Blomkvist Preamble I discussed how pharmaceutical selling is likely to change during the next five years. Now, this is a broad vision of how pharmaceutical marketing may look like by 2030, with a special lens on Pakistan. It is more complex than selling because marketing is the brain and it works for present and future simultaneously. What will change materially by 2030 Omnichannel becomes the default, not “digital vs. rep,” but both. HCPs increasingly want integrated experiences across rep visits, virtual touchpoints, portals, webinars, medical content hubs, and peer channels. Medical and commercial touchpoints will be o...

Pharma Selling in Five Years – The Shape of Things to Come – Asrar Qureshi’s Blog Post #1147 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1147 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Abdul Batin Credit: Antoni Shkraba Credit: Tima Miroshnichenko Preamble This is a broad vision of how pharmaceutical selling may look like by 2030. The Current Reality Pharmaceutical selling is still heavily relationship driven. Doctors, pharmacists, and hospital buyers trust sales reps who bring credibility, responsiveness, and personalized discussions. Unlike many other industries, face-to-face selling continues to dominate because: Prescribers rely on human interaction and nuanced discussions. Regulatory restrictions limit direct-to-consumer pharma marketing in many countries, particularly Pakistan Complex therapies (...

Underground AI in Workplace – Asrar Qureshi’s Blog Post #1145 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1145 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com . Please email to pharmaveterans2017@gmail.com   for publishing your contributions here. Mikhail Nilov Mikhail Nilov Preamble This blog post takes key insights from HR Dive’s article “Younger employees use AI at work but don’t want to tell their bosses”, and couple of other articles on the same subject. It reflects workplace trends, underlying anxieties, and steps managers can take to bring clarity and trust in AI adoption. When AI Goes Underground: What It Means When Employees Don’t Tell Their Bosses In workplaces across the U.S., a surprising trend has taken root: many younger employees are secretly using AI tools at work and deliberately keeping it under wraps. According to a recent HR Dive report, nearly half of Generation Z and millennial ...

HR Monitor 2025 by McKinsey Part 3 – Asrar Qureshi’s Blog Post #1141 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1141 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Cedric Fauntleroy Credit: Tran Nhu Tuan Credit: Pavel Danilyuk Continued from Part 2… Preamble McKinsey report HR Monitor 2025 highlights the following trends that HR managers/leaders should recognize, understand, and work on. We took the first two in the last blog post; the others we shall take up in this and following post(s) and then conclude the topic. Five Trends That HR Leaders Must Recognize 1. Workforce planning is not approached strategically enough 2. Talent acquisition is becoming more complex 3. Employee development continues to be highly fragmented  4. Employee experience is essential 5. Gen AI and shared-services ce...

Supporting Serendipity in the World of Algorithms – Asrar Qureshi’s Blog Post #1114 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1114 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Gustavo Fring Credit: Ron Lach Preamble 2wIn today's digital ecosystem, algorithms dictate much of what we see, hear, and buy. From the videos recommended on YouTube to the products shown on Amazon, artificial intelligence (AI)-driven recommendation systems work tirelessly behind the scenes to personalize our experiences. These algorithms are designed to optimize relevance and engagement by curating content based on our past behaviors. But while this convenience is often welcomed, it raises an important concern: are we trading serendipity and self-discovery for efficiency and predictability? Klaus Wertenbroch's INSEAD article...

AI and Mental Health Support – Availability, Reliability and Concerns– Asrar Qureshi’s Blog Post #1112 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1112 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Alexy Almond Credit: Matias Mango Preamble In an era where artificial intelligence (AI) is permeating every aspect of our lives, from finance to fitness, it's no surprise that mental health support is also being influenced by this powerful technology. As mental health challenges become more common and accessible care remains scarce in many regions, AI-driven tools are emerging as potential game-changers. But should we truly rely on AI for something as sensitive and complex as mental health? The Rising Role of AI in Mental Health Mental health care is grappling with unprecedented demand. Long waitlists, limited ...

AI and Machine Learning in Pharmaceutical Drug Development – Asrar Qureshi’s Blog Post #1102 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1102 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: cottonbro studio Credit: Rui Dias Credit: YI REN This blogpost is inspired by interview of GSK’s Global Head of AI and Machine Learning, Kim Branson, by McKinsey panel. Link at the end Preamble The pharmaceutical industry is undergoing a profound transformation. With rising R&D costs, extended development timelines, and increasing regulatory scrutiny, innovation is no longer optional—it is essential. Among the most disruptive enablers of this transformation are Artificial Intelligence (AI) and Machine Learning (ML). These technologies are rapidly changing the way drugs are discovered, developed, and delivered. From e...

Influence of Gen AI on Pharmaceutical Marketing – Now and in Five Years – Asrar Qureshi’s Blog Post #1088 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1088 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: fauxels Credit: Polina Tankilevich Credit: This is Engineering Preamble It is a foregone conclusion that the Generative Artificial Intelligence – Gen AI or simply AI – has already started influencing every walk of life. The pace of change is so rapid that it has become difficult to keep adjusting with it. But we must keep pace with the changing landscape to survive respectably or risk to be perished. In this blog post, we see how AI has already influenced pharmaceutical marketing. We shall also try to visualize the next five years and the possible changes that might be coming. My reference is not strictly lo...

Five AI Trends to Watch in 2025 (and Beyond) – Asrar Qureshi’s Blog Post #1061 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1061 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here. Credit: Brett Sayles Credit: Christina Morillo Credit: Ron Lach This post is inspired by an article by Rob Howard of https://innovatingwithai.com and PWC report. Link at the end. Preamble I keep returning to the topic of AI because it is the most happening field right now and shall remain so for the next several years.  According to PWC (Price Waterhouse Cooper) global report, Artificial Intelligence shall cause to increase global GDP by 14% in 2030. This will be the equivalent of additional $15.7 trillion. The report highlights that: • Labor productivity improvements will drive initial GDP gains as firms seek to augment the productivity of ...